優德精密(300549.SZ):控股子公司擬設立青島分公司
格隆匯 12 月 25日丨優德精密(300549.SZ)公佈,公司於2020年12月25日召開了第三屆董事會第十一次會議,審議通過了《關於控股子公司設立青島分公司的議案》,同意控股子公司崑山德系智能裝備有限公司擬在青島市設立分公司。
此次控股子公司在青島設立分公司目的是為了更好的維護與開拓華北地區業務市場,是從子公司的發展規劃和實際需要提出,符合公司的整體發展規劃。但可能存在一定的市場風險、管理風險,公司將進一步規範子公司治理結構、健全內控制度,加強風險防範,以適應市場變化,滿足業務發展的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.